- Home
- NVCR vs TY Comparison
NVCR vs TY Comparison
Compare NVCR & TY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- TY
- Stock Information
- Founded
- NVCR 2000
- TY 1929
- Country
- NVCR Switzerland
- TY United States
- Employees
- NVCR N/A
- TY N/A
- Industry
- NVCR Medical/Dental Instruments
- TY Finance Companies
- Sector
- NVCR Health Care
- TY Finance
- Exchange
- NVCR Nasdaq
- TY Nasdaq
- Market Cap
- NVCR 1.9B
- TY 1.6B
- IPO Year
- NVCR 2015
- TY N/A
- Fundamental
- Price
- NVCR $16.69
- TY $30.64
- Analyst Decision
- NVCR Buy
- TY
- Analyst Count
- NVCR 6
- TY 0
- Target Price
- NVCR $32.83
- TY N/A
- AVG Volume (30 Days)
- NVCR 1.6M
- TY 43.0K
- Earning Date
- NVCR 07-24-2025
- TY 01-01-0001
- Dividend Yield
- NVCR N/A
- TY 3.36%
- EPS Growth
- NVCR N/A
- TY N/A
- EPS
- NVCR N/A
- TY 4.78
- Revenue
- NVCR $621,711,000.00
- TY N/A
- Revenue This Year
- NVCR $5.56
- TY N/A
- Revenue Next Year
- NVCR $9.19
- TY N/A
- P/E Ratio
- NVCR N/A
- TY $6.38
- Revenue Growth
- NVCR 18.27
- TY N/A
- 52 Week Low
- NVCR $14.17
- TY $25.16
- 52 Week High
- NVCR $34.13
- TY $30.73
- Technical
- Relative Strength Index (RSI)
- NVCR 43.44
- TY 41.15
- Support Level
- NVCR $17.20
- TY $30.53
- Resistance Level
- NVCR $18.02
- TY $32.12
- Average True Range (ATR)
- NVCR 1.04
- TY 0.37
- MACD
- NVCR -0.09
- TY -0.16
- Stochastic Oscillator
- NVCR 15.51
- TY 13.66
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About TY Tri Continental Corporation
Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.